JAMA Dermatology

<jats:sec><jats:title>Importance</jats:title><jats:p>Clinician-guided online self-help based on cognitive behavioral therapy (CBT) has been shown to be effective at decreasing symptom severity for people with atopic dermatitis (AD). A brief online self-guided CBT intervention could be more cost-effective and allow for easy implementation and broader outreach compared with more comprehensive clinician-guided interventions.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>To investigate whether a brief online self-guided CBT intervention is noninferior to a comprehensive online clinician-guided CBT treatment.</jats:p></jats:sec><jats:sec><jats:title>Design, Setting, and Participants</jats:title><jats:p>This single-blind randomized clinical noninferiority trial was conducted at Karolinska Institutet, Stockholm, Sweden. Adult individuals with AD were enrolled from November 2022 to April 2023. The last postintervention data were collected in December 2023.</jats:p></jats:sec><jats:sec><jats:title>Interventions</jats:title><jats:p>Participants randomized to the self-guided group had access to a self-guided online CBT intervention for 12 weeks without clinician support. Participants randomized to the clinician-guided group received online CBT for 12 weeks.</jats:p></jats:sec><jats:sec><jats:title>Main Outcomes and Measures</jats:title><jats:p>The primary outcome was change in score from baseline to postintervention to 12-week follow-up on the self-reported Patient-Oriented Eczema Measure (POEM). The predefined noninferiority margin was 3 points on POEM.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 168 randomized participants, 142 (84.5%) were female, and the mean (SD) age was 39 (10.5) years. A total of 86 participants were randomized to the self-guided group and 82 were randomized to the clinician-guided group. A total of 151 (90.0%) completed the main outcome postintervention assessment. Postintervention, the clinician-guided group had improved 4.20 points (95% CI, 1.94-6.05) on POEM and the self-guided group improved 4.60 points (95% CI, 2.57-6.64), corresponding to an estimated mean difference in change of 0.36 points (1-sided 97.5% CI, −∞ to 1.75), which was below the noninferiority margin of 3 points. No serious adverse events were reported. In the clinician-guided group, clinicians spent a mean (SD) of 36.0 (33.3) minutes (95% CI, 29.2-41.7) on treatment guidance and 14.0 (6.0) minutes (95% CI, 12.9-15.6) on assessments compared to 15.8 (6.4) minutes on assessments in the self-guided group.</jats:p></jats:sec><jats:sec><jats:title>Conclusions and Relevance</jats:title><jats:p>In this randomized clinical noninferiority trial, a brief self-guided CBT intervention was noninferior to clinician-guided CBT. Given the limited clinical resources required to deliver self-guided CBT, this treatment might be a promising means to disseminate evidence-based psychological treatment for patients with AD.</jats:p></jats:sec><jats:sec><jats:title>Trial Registration</jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/study/NCT05517850">NCT05517850</jats:ext-link></jats:p></jats:sec>

The burden of atopic dermatitis: summary of a report for the National Eczema Association.

J Invest Dermatol

Atopic dermatitis.

Lancet

Itch and atopic dermatitis: an overview.

J Dermatol

Habit reversal for refractory atopic dermatitis: a review.

Br J Dermatol

Cognitive, behavioral, and physiological reactivity to chronic itching: analogies to chronic pain.

Int J Behav Med

Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis.

World Psychiatry

Cognitive behavior therapy as dermatological treatment: a narrative review.

Int J Womens Dermatol

Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial.

Cogn Behav Ther

Internet-delivered cognitive behavior therapy for atopic dermatitis: a randomized clinical trial.

JAMA Dermatol

Optimized user experience, efficiency, and resource use in online self-management of atopic dermatitis.

A digital self-help intervention for atopic dermatitis: analysis of secondary outcomes from a feasibility study.

JMIR Dermatol

The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective.

Arch Dermatol

Brief self-guided digital intervention versus a comprehensive therapist-guided online cognitive behavioural therapy for atopic dermatitis: a trial protocol for a randomised non-inferiority trial.

BMJ Open

Transforming guided internet interventions into simplified and self-guided digital tools—experiences from three recent projects.

Internet Interv

EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference.

Allergy

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.

A global measure of perceived stress.

J Health Soc Behav

The PHQ-9: validity of a brief depression severity measure.

J Gen Intern Med

Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use.

Clin Exp Dermatol

The Client Satisfaction Questionnaire. psychometric properties and correlations with service utilization and psychotherapy outcome.

Eval Program Plann

Psychometric properties of the Credibility/Expectancy Questionnaire.

J Behav Ther Exp Psychiatry

Non-inferiority statistics and equivalence studies.

BJA Educ

The concept and components of engagement in different domains applied to eHealth: a systematic scoping review.

Front Psychol

Are behavioral interventions a better choice for atopic dermatitis patients? a meta-analysis of 6 randomized controlled trials.

An Bras Dermatol

Clinician-guided online self-help based on cognitive behavioral therapy (CBT) has been shown to be effective at decreasing symptom severity for people with atopic dermatitis (AD). A brief online self-guided CBT intervention could be more cost-effective and allow for easy implementation and broader outreach compared with more comprehensive clinician-guided interventions.
To investigate whether a brief online self-guided CBT intervention is noninferior to a comprehensive online clinician-guided CBT treatment.
This single-blind randomized clinical noninferiority trial was conducted at Karolinska Institutet, Stockholm, Sweden. Adult individuals with AD were enrolled from November 2022 to April 2023. The last postintervention data were collected in December 2023.
Participants randomized to the self-guided group had access to a self-guided online CBT intervention for 12 weeks without clinician support. Participants randomized to the clinician-guided group received online CBT for 12 weeks.
The primary outcome was change in score from baseline to postintervention to 12-week follow-up on the self-reported Patient-Oriented Eczema Measure (POEM). The predefined noninferiority margin was 3 points on POEM.
Of 168 randomized participants, 142 (84.5%) were female, and the mean (SD) age was 39 (10.5) years. A total of 86 participants were randomized to the self-guided group and 82 were randomized to the clinician-guided group. A total of 151 (90.0%) completed the main outcome postintervention assessment. Postintervention, the clinician-guided group had improved 4.20 points (95% CI, 1.94-6.05) on POEM and the self-guided group improved 4.60 points (95% CI, 2.57-6.64), corresponding to an estimated mean difference in change of 0.36 points (1-sided 97.5% CI, -∞ to 1.75), which was below the noninferiority margin of 3 points. No serious adverse events were reported. In the clinician-guided group, clinicians spent a mean (SD) of 36.0 (33.3) minutes (95% CI, 29.2-41.7) on treatment guidance and 14.0 (6.0) minutes (95% CI, 12.9-15.6) on assessments compared to 15.8 (6.4) minutes on assessments in the self-guided group.
In this randomized clinical noninferiority trial, a brief self-guided CBT intervention was noninferior to clinician-guided CBT. Given the limited clinical resources required to deliver self-guided CBT, this treatment might be a promising means to disseminate evidence-based psychological treatment for patients with AD.
ClinicalTrials.gov Identifier: NCT05517850.

Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis: A Randomized Clinical Trial.

Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis

Self-Guided vs Clinician-Guided Online Cognitive Behavioral Therapy for Atopic Dermatitis

Clinical Summary

What was studied

Key findings

Study limitations

Clinical implications

Related Questions